» Articles » PMID: 36971722

COVID-19-Related Changes to Drug-Selling Networks and Their Effects on People Who Use Illicit Opioids

Overview
Specialty Psychiatry
Date 2023 Mar 27
PMID 36971722
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The COVID-19 pandemic has significantly affected people's ability to buy, sell, and obtain items that they use in their daily lives. It may have had a particularly negative effect on the ability of people who use illicit opioids to obtain them because the networks they relied on are illicit and not part of the formal economy. Our objective in this research was to examine if, and how, disruptions related to COVID-19 of illicit opioid markets have affected people who use illicit opioids.

Method: We collected 300 posts--including replies to posts--related to the intersection of COVID-19 and opioid use from Reddit.com, a forum that has several discussion threads (i.e., subreddits) dedicated to opioids. We then coded posts from the two most popular opioid subreddits during the early pandemic period (March 5, 2020-May 13, 2020) using an inductive/deductive approach.

Results: We found two themes related to active opioid use during the early pandemic: (a) changes in drug supply and difficulty obtaining opioids, and (b) buying less-trustworthy drugs from lesser-known sources.

Conclusions: Our findings suggest that COVID-19 has created market conditions that place people who use opioids at risk of adverse outcomes, such as fatal overdose.

Citing Articles

Navigating the COVID-19 Risk Environment, Overdose Prevention, and Self Care Practices of People Who Use Illicit Opioids in New York City.

Bennett A, McCollum Jr D, Elliott L Subst Use Misuse. 2024; 60(4):504-514.

PMID: 39623307 PMC: 11825269. DOI: 10.1080/10826084.2024.2434681.


COVID-19 public health restrictions and opioid overdoes: a summative content analysis of emergency medical services records in three Texas counties.

Graham S, Sharma N, Hooker T, Harrison K, Claborn K Subst Abuse Treat Prev Policy. 2024; 19(1):45.

PMID: 39516912 PMC: 11545770. DOI: 10.1186/s13011-024-00627-5.


Fentanyl, Heroin, Methamphetamine, and Cocaine Analyte Concentrations in Urine Drug Testing Specimens.

Huhn A, Whitley P, Bolin B, Dunn K JAMA Netw Open. 2024; 7(10):e2441063.

PMID: 39446323 PMC: 11577146. DOI: 10.1001/jamanetworkopen.2024.41063.


Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative.

Walters S, Baker R, Frank D, Fadanelli M, Rudolph A, Zule W Harm Reduct J. 2024; 21(1):154.

PMID: 39182116 PMC: 11344336. DOI: 10.1186/s12954-024-01062-2.


Enhancing drug checking services for supply monitoring: perspectives on implementation in syringe service programs in the USA.

Moon K, Whitehead H, Trinh A, Hasenstab K, Hayes K, Stanley D Harm Reduct J. 2024; 21(1):11.

PMID: 38218980 PMC: 10788002. DOI: 10.1186/s12954-023-00924-5.


References
1.
Green T, Gilbert M . Counterfeit Medications and Fentanyl. JAMA Intern Med. 2016; 176(10):1555-1557. DOI: 10.1001/jamainternmed.2016.4310. View

2.
Kazdin A . Unobtrusive measures in behavioral assessment. J Appl Behav Anal. 1979; 12(4):713-24. PMC: 1311490. DOI: 10.1901/jaba.1979.12-713. View

3.
Becker W, Fiellin D . When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis. Ann Intern Med. 2020; 173(1):59-60. PMC: 7138333. DOI: 10.7326/M20-1210. View

4.
Walters S, Seal D, Stopka T, Murphy M, Jenkins W . COVID-19 and People Who Use Drugs - A Commentary. Health Behav Policy Rev. 2020; 7(5):489-497. PMC: 7595339. DOI: 10.14485/hbpr.7.5.11. View

5.
Niles J, Gudin J, Radcliff J, Kaufman H . The Opioid Epidemic Within the COVID-19 Pandemic: Drug Testing in 2020. Popul Health Manag. 2020; 24(S1):S43-S51. PMC: 7875135. DOI: 10.1089/pop.2020.0230. View